Home LiteratureArticle Details
PMID: 1727430 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Evidence for a hyperexcitability state of staggerer mutant mice macrophages.

Journal of neurochemistry ·Vol. 58 ·No. 1 ·1992-01-00 ·Pages 192-9

Kopmels B, Mariani J, Delhaye-Bouchaud N, Audibert F, Fradelizi D, Wollman EE

Abstract

We recently reported an abnormal production of interleukin-1 (IL-1) in peripheral macrophages of several neurological mutant mice that exhibit patterns of neuronal degeneration, especially in the cerebellum. After in vitro activation by lipopolysaccharide acid (LPS), these macrophages hyperexpress IL-1 beta mRNA and hyperproduce IL-1 protein in comparison with +/+ controls. In the present study, focused on the staggerer mutant mice, we investigate if this genetic dysregulation is specific for IL-1 beta or if it reflects a generalized hyperexcitability of these macrophages. The hyperexpression of IL-1 beta mRNA in sg/sg macrophages is present whatever the duration of LPS stimulation, even for periods as short as 15 min, although it reaches a maximum after 4 h of stimulation. The hyperinducibility of sg/sg macrophages is observed even when very low doses of LPS are used (0.01 microgram/ml) and reaches its maximum for 5 micrograms/ml LPS. Synthetic molecules (muramyl dipeptides), such as N-acetylmuramyl-L-alanyl-D-isoglutamine or murabutide, known as macrophage activators, are also efficient in revealing the cytokine hyperexpression in sg/sg macrophages. In addition, hyperexpression of two other cytokines, i.e., tumor necrosis factor-alpha and IL-1 alpha mRNAs, is also detected in LPS-stimulated macrophages of mutant mice. Finally, the effect of an inhibitor of protein synthesis, cycloheximide, is similar in +/+ and sg/sg macrophages. As a whole, these data lead us to conclude that the sg/sg macrophages are in a state of general hyperexcitability when compared with +/+ ones.

MeSH Terms
Acetylmuramyl-Alanyl-Isoglutamine/analogs & derivatives,pharmacology Animals Cycloheximide/pharmacology Dose-Response Relationship, Drug Interleukin-1/genetics Lipopolysaccharides Macrophages/drug effects,metabolism,physiology Mice Mice, Neurologic Mutants/physiology RNA, Messenger/metabolism Tumor Necrosis Factor-alpha/pharmacology
Chemicals
Interleukin-1 Lipopolysaccharides RNA, Messenger Tumor Necrosis Factor-alpha Acetylmuramyl-Alanyl-Isoglutamine murabutide Cycloheximide
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Kopmels B
Laboratoire d'Immunologie, URA1156, Institut Gustave Roussy, Centre National de la Recherche Scientifique, Institut de la Santé et de la Recherche Médicale, Villejuif, France.
Mariani J
Delhaye-Bouchaud N
Audibert F
Fradelizi D
Wollman E E
Article Info
Journal
Journal of neurochemistry
Abbr.
J Neurochem
ISSN
0022-3042
Published
1992-01-00
Pages
192-9
Language
English
Region
England
NLM ID
2985190R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com